Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:tocilizumab
|
| gptkbp:affiliatedWith |
gptkb:monoclonal_antibody
immunosuppressant |
| gptkbp:approvedBy |
gptkb:European_Union
2009 |
| gptkbp:ATCCode |
L04AC07
|
| gptkbp:brand |
gptkb:tocilizumab
|
| gptkbp:contraindication |
active severe infections
|
| gptkbp:form |
solution for injection
solution for infusion |
| https://www.w3.org/2000/01/rdf-schema#label |
RoActemra (Europe)
|
| gptkbp:indication |
gptkb:juvenile_idiopathic_arthritis
gptkb:giant_cell_arteritis rheumatoid arthritis cytokine release syndrome |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Roche
|
| gptkbp:mechanismOfAction |
IL-6 receptor antagonist
|
| gptkbp:routeOfAdministration |
subcutaneous
intravenous |
| gptkbp:sideEffect |
hypertension
infections elevated liver enzymes neutropenia |
| gptkbp:bfsParent |
gptkb:Actemra
|
| gptkbp:bfsLayer |
7
|